Skip to content

13F-HR filed by Velan Capital Investment Management LP

Velan Capital Investment Management LP filed this 13F-HR for the quarter ended 2023-03-31, filed 2023-05-15, with 31 holding rows worth $117,314,326.

Accession
0001848809-23-000002
Filed
2023-05-15
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q1 2023

A holdings report, 31 entries on the cover page, a total value of $117,314,326 stated on the cover page (in dollars after the unit check, H1), rows summing to $117,314,326 with VALUE read as dollars as filed, 13F file number 028-21996. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
JASPER THERAPEUTICS INC471871103COM11,219,036$19,617,289dollars as filed
ADMA BIOLOGICS INC000899104COM4,000,000$13,240,000dollars as filed
LANTHEUS HLDGS INC516544103COM150,000$12,384,000dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR200,000$9,888,000dollars as filed
TELA BIO INC872381108COM746,087$7,938,366dollars as filed
HERON THERAPEUTICS INC427746102COM4,500,000$6,795,000dollars as filed
OPTINOSE INC68404V100COM3,496,861$6,748,942dollars as filed
QUIPT HOME MEDICAL CORP74880P104COM800,000$5,608,000dollars as filed
SPDR INDEX SHS FDS78463X202EURO STOXX 50100,000$4,490,000dollars as filedput
PRAXIS PRECISION MEDICINES I74006W108COM5,185,000$4,194,665dollars as filed
POINT BIOPHARMA GLOBAL INC730541109COM494,136$3,592,369dollars as filed
CATALENT INC USD 0.01148806102COM50,000$3,285,500dollars as filed
TENET HEALTHCARE CORP COM NEW88033G407Stock51,900$3,083,898dollars as filed
GALERA THERAPEUTICS EQUICLASS EQUITY36338D108COMMON STOCK1,000,000$2,560,000dollars as filed
CABALETTA BIO INC12674W109COMMON STOCK250,000$2,067,500dollars as filed
89BIO INC282559103COM98,500$1,500,155dollars as filed
TERNS PHARMACEUTICALS INC COM880881107Stock120,000$1,420,800dollars as filed
IOVANCE BIOTHERAPEUTICS INC462260100COM220,000$1,344,200dollars as filed
EDESA BIOTECH INC27966L108COM1,281,615$1,168,961dollars as filed
THESEUS PHARMACEUTICALS INC88369M101COM100,000$888,000dollars as filed
ICOSAVAX INC45114M109COM150,000$870,000dollars as filed
REZOLUTE INC76200L309COMMON STOCK400,000$768,000dollars as filed
GERON CORP374163103COM300,000$651,000dollars as filed
SONIDA SENIOR LIVING INC140475203COMMON STOCK82,832$562,429dollars as filed
ALIMERA SCIENCES INC016259202COM257,753$541,281dollars as filed
COLLEGIUM PHARMACEUTICAL INC19459J104COM22,095$530,059dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock23,400$500,526dollars as filed
ANNEXON INC03589W102COM100,000$385,000dollars as filed
DISC MEDICINE INC COM254604101Stock12,269$259,980dollars as filed
AVADEL PHARMACEUTICALS, PLC05337M104COMMON STOCK-FO25,743$235,806dollars as filed
BOLT BIOTHERAPEUTICS INC097702104COM140,000$194,600dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001848809-23-000002this filing2023-05-15acceptance time not in the bulk data set